APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Pet Medication

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global OTC Pet Medication Market Outlook and Growth Opportunities 2026

31 December 2025197 pages

Choose your research edition.

Industry ResearchOTC Pet Medication Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Pet Medication Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal OTC Pet Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Pet Medication Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Pet Medication Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global OTC Pet Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for OTC Pet Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OTC Pet Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Pet Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the OTC Pet Medication market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the OTC Pet Medication market include Merck Inc., Zymox, Zoetis Inc., Virbac SA, Vetoquinol SA, Sulfox, Nutramax Laboratories, Inc., Frontline and Elanco, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global OTC Pet Medication market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OTC Pet Medication and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OTC Pet Medication revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global OTC Pet Medication market.

OTC Pet Medication Segment by Company

Merck Inc.

Zymox

Zoetis Inc.

Virbac SA

Vetoquinol SA

Sulfox

Nutramax Laboratories, Inc.

Frontline

Elanco

Dechra Pharmaceuticals PLC

ChloraSeb

Ceva Sante Animale

Boehringer Ingelheim Animal Health

Bayer Companion Animal

Adequan

OTC Pet Medication Segment by Type

Dewormers

Fleas & Ticks Removal

Pain Relief & Arthritis

Others

OTC Pet Medication Segment by Application

Fish & Reptiles

Birds

Dogs & Cats

Others

OTC Pet Medication Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global OTC Pet Medication status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the OTC Pet Medication key companies, revenue, market share, and recent developments.

3. To split the OTC Pet Medication breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions OTC Pet Medication market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify OTC Pet Medication significant trends, drivers, influence factors in global and regions.

6. To analyze OTC Pet Medication competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Pet Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Pet Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Pet Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global OTC Pet Medication industry.

Chapter 3: Detailed analysis of OTC Pet Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of OTC Pet Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of OTC Pet Medication in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. OTC Pet Medication Industry Trends Table 2. OTC Pet Medication Industry Drivers Table 3. OTC Pet Medication Industry Opportunities and Challenges Table 4. OTC Pet Medication Industry Restraints Table 5. Global OTC Pet Medication Revenue by Company (US$ Million) & (2021-2026) Table 6. Global OTC Pet Medication Revenue Share by Company (2021-2026) Table 7. Global OTC Pet Medication Company Ranking, (2024-2026) & (US$ Million) Table 8. Global OTC Pet Medication Key Company Manufacturing Base & Headquarters Table 9. Global OTC Pet Medication Company, Product Type & Application Table 10. Global OTC Pet Medication Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global OTC Pet Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Dewormers Table 15. Significant Companies of Fleas & Ticks Removal Table 16. Significant Companies of Pain Relief & Arthritis Table 17. Significant Companies of Others Table 18. Global OTC Pet Medication Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global OTC Pet Medication Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global OTC Pet Medication Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global OTC Pet Medication Sales Value Share by Type (2021-2026) Table 22. Global OTC Pet Medication Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Fish & Reptiles Table 24. Significant Companies of Birds Table 25. Significant Companies of Dogs & Cats Table 26. Significant Companies of Others Table 27. Global OTC Pet Medication Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global OTC Pet Medication Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global OTC Pet Medication Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global OTC Pet Medication Sales Value Share by Application (2021-2026) Table 31. Global OTC Pet Medication Sales Value Share by Application (2027-2032) Table 32. Global OTC Pet Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global OTC Pet Medication Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global OTC Pet Medication Sales Value Share by Region (2021-2026) Table 35. Global OTC Pet Medication Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global OTC Pet Medication Sales Value Share by Region (2027-2032) Table 37. Global OTC Pet Medication Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global OTC Pet Medication Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global OTC Pet Medication Sales Value Market Share by Country (2021-2026) Table 40. Global OTC Pet Medication Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global OTC Pet Medication Sales Value Market Share by Country (2027-2032) Table 42. Merck Inc. Company Information Table 43. Merck Inc. Business Overview Table 44. Merck Inc. OTC Pet Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Merck Inc. OTC Pet Medication Product Portfolio Table 46. Merck Inc. Recent Development Table 47. Zymox Company Information Table 48. Zymox Business Overview Table 49. Zymox OTC Pet Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Zymox OTC Pet Medication Product Portfolio Table 51. Zymox Recent Development Table 52. Zoetis Inc. Company Information Table 53. Zoetis Inc. Business Overview Table 54. Zoetis Inc. OTC Pet Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Zoetis Inc. OTC Pet Medication Product Portfolio Table 56. Zoetis Inc. Recent Development Table 57. Virbac SA Company Information Table 58. Virbac SA Business Overview Table 59. Virbac SA OTC Pet Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Virbac SA OTC Pet Medication Product Portfolio Table 61. Virbac SA Recent Development Table 62. Vetoquinol SA Company Information Table 63. Vetoquinol SA Business Overview Table 64. Vetoquinol SA OTC Pet Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Vetoquinol SA OTC Pet Medication Product Portfolio Table 66. Vetoquinol SA Recent Development Table 67. Sulfox Company Information Table 68. Sulfox Business Overview Table 69. Sulfox OTC Pet Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Sulfox OTC Pet Medication Product Portfolio Table 71. Sulfox Recent Development Table 72. Nutramax Laboratories, Inc. Company Information Table 73. Nutramax Laboratories, Inc. Business Overview Table 74. Nutramax Laboratories, Inc. OTC Pet Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Nutramax Laboratories, Inc. OTC Pet Medication Product Portfolio Table 76. Nutramax Laboratories, Inc. Recent Development Table 77. Frontline Company Information Table 78. Frontline Business Overview Table 79. Frontline OTC Pet Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Frontline OTC Pet Medication Product Portfolio Table 81. Frontline Recent Development Table 82. Elanco Company Information Table 83. Elanco Business Overview Table 84. Elanco OTC Pet Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Elanco OTC Pet Medication Product Portfolio Table 86. Elanco Recent Development Table 87. Dechra Pharmaceuticals PLC Company Information Table 88. Dechra Pharmaceuticals PLC Business Overview Table 89. Dechra Pharmaceuticals PLC OTC Pet Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Dechra Pharmaceuticals PLC OTC Pet Medication Product Portfolio Table 91. Dechra Pharmaceuticals PLC Recent Development Table 92. ChloraSeb Company Information Table 93. ChloraSeb Business Overview Table 94. ChloraSeb OTC Pet Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. ChloraSeb OTC Pet Medication Product Portfolio Table 96. ChloraSeb Recent Development Table 97. Ceva Sante Animale Company Information Table 98. Ceva Sante Animale Business Overview Table 99. Ceva Sante Animale OTC Pet Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Ceva Sante Animale OTC Pet Medication Product Portfolio Table 101. Ceva Sante Animale Recent Development Table 102. Boehringer Ingelheim Animal Health Company Information Table 103. Boehringer Ingelheim Animal Health Business Overview Table 104. Boehringer Ingelheim Animal Health OTC Pet Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Boehringer Ingelheim Animal Health OTC Pet Medication Product Portfolio Table 106. Boehringer Ingelheim Animal Health Recent Development Table 107. Bayer Companion Animal Company Information Table 108. Bayer Companion Animal Business Overview Table 109. Bayer Companion Animal OTC Pet Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Bayer Companion Animal OTC Pet Medication Product Portfolio Table 111. Bayer Companion Animal Recent Development Table 112. Adequan Company Information Table 113. Adequan Business Overview Table 114. Adequan OTC Pet Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Adequan OTC Pet Medication Product Portfolio Table 116. Adequan Recent Development Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. OTC Pet Medication Product Image Figure 2. Global OTC Pet Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Pet Medication Market Size (2021-2032) & (US$ Million) Figure 4. Global OTC Pet Medication Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Dewormers Image Figure 8. Fleas & Ticks Removal Image Figure 9. Pain Relief & Arthritis Image Figure 10. Others Image Figure 11. Global OTC Pet Medication Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global OTC Pet Medication Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global OTC Pet Medication Sales Value Share by Type (2021-2032) Figure 14. Fish & Reptiles Image Figure 15. Birds Image Figure 16. Dogs & Cats Image Figure 17. Others Image Figure 18. Global OTC Pet Medication Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global OTC Pet Medication Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global OTC Pet Medication Sales Value Share by Application (2021-2032) Figure 21. Global OTC Pet Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global OTC Pet Medication Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America OTC Pet Medication Sales Value (2021-2032) & (US$ Million) Figure 24. North America OTC Pet Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe OTC Pet Medication Sales Value (2021-2032) & (US$ Million) Figure 26. Europe OTC Pet Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific OTC Pet Medication Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific OTC Pet Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America OTC Pet Medication Sales Value (2021-2032) & (US$ Million) Figure 30. South America OTC Pet Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa OTC Pet Medication Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa OTC Pet Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt OTC Pet Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt OTC Pet Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt OTC Pet Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Dewormers
  • Fleas & Ticks Removal
  • Pain Relief & Arthritis
  • Others
Applications
  • Fish & Reptiles
  • Birds
  • Dogs & Cats
  • Others
Companies covered
  • Merck Inc.
  • Zymox
  • Zoetis Inc.
  • Virbac SA
  • Vetoquinol SA
  • Sulfox
  • Nutramax Laboratories, Inc.
  • Frontline
  • Elanco
  • Dechra Pharmaceuticals PLC
  • ChloraSeb
  • Ceva Sante Animale
  • Boehringer Ingelheim Animal Health
  • Bayer Companion Animal
  • Adequan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global OTC Pet Medication Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global OTC Pet Medication Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 OTC Pet Medication Market Dynamics
  1. 2.1 OTC Pet Medication Industry Trends
  2. 2.2 OTC Pet Medication Industry Drivers
  3. 2.3 OTC Pet Medication Industry Opportunities and Challenges
  4. 2.4 OTC Pet Medication Industry Restraints
3 OTC Pet Medication Market by Company
  1. 3.1 Global OTC Pet Medication Company Revenue Ranking in 2025
  2. 3.2 Global OTC Pet Medication Revenue by Company (2021-2026)
  3. 3.3 Global OTC Pet Medication Company Ranking (2024-2026)
  4. 3.4 Global OTC Pet Medication Company Manufacturing Base and Headquarters
  5. 3.5 Global OTC Pet Medication Company Product Type and Application
  6. 3.6 Global OTC Pet Medication Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global OTC Pet Medication Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 OTC Pet Medication Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 OTC Pet Medication Market by Type
  1. 4.1 OTC Pet Medication Type Introduction
  2. 4.1.1 Dewormers
  3. 4.1.2 Fleas & Ticks Removal
  4. 4.1.3 Pain Relief & Arthritis
  5. 4.1.4 Others
  6. 4.2 Global OTC Pet Medication Sales Value by Type
  7. 4.2.1 Global OTC Pet Medication Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global OTC Pet Medication Sales Value by Type (2021-2032)
  9. 4.2.3 Global OTC Pet Medication Sales Value Share by Type (2021-2032)
5 OTC Pet Medication Market by Application
  1. 5.1 OTC Pet Medication Application Introduction
  2. 5.1.1 Fish & Reptiles
  3. 5.1.2 Birds
  4. 5.1.3 Dogs & Cats
  5. 5.1.4 Others
  6. 5.2 Global OTC Pet Medication Sales Value by Application
  7. 5.2.1 Global OTC Pet Medication Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global OTC Pet Medication Sales Value by Application (2021-2032)
  9. 5.2.3 Global OTC Pet Medication Sales Value Share by Application (2021-2032)
6 OTC Pet Medication Regional Value Analysis
  1. 6.1 Global OTC Pet Medication Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global OTC Pet Medication Sales Value by Region (2021-2032)
  3. 6.2.1 Global OTC Pet Medication Sales Value by Region: 2021-2026
  4. 6.2.2 Global OTC Pet Medication Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America OTC Pet Medication Sales Value (2021-2032)
  7. 6.3.2 North America OTC Pet Medication Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe OTC Pet Medication Sales Value (2021-2032)
  10. 6.4.2 Europe OTC Pet Medication Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific OTC Pet Medication Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific OTC Pet Medication Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America OTC Pet Medication Sales Value (2021-2032)
  16. 6.6.2 South America OTC Pet Medication Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa OTC Pet Medication Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa OTC Pet Medication Sales Value Share by Country, 2025 VS 2032
7 OTC Pet Medication Country-level Value Analysis
  1. 7.1 Global OTC Pet Medication Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global OTC Pet Medication Sales Value by Country (2021-2032)
  3. 7.2.1 Global OTC Pet Medication Sales Value by Country (2021-2026)
  4. 7.2.2 Global OTC Pet Medication Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA OTC Pet Medication Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada OTC Pet Medication Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico OTC Pet Medication Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany OTC Pet Medication Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France OTC Pet Medication Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. OTC Pet Medication Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy OTC Pet Medication Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain OTC Pet Medication Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia OTC Pet Medication Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands OTC Pet Medication Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries OTC Pet Medication Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China OTC Pet Medication Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan OTC Pet Medication Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea OTC Pet Medication Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India OTC Pet Medication Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia OTC Pet Medication Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia OTC Pet Medication Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil OTC Pet Medication Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina OTC Pet Medication Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile OTC Pet Medication Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia OTC Pet Medication Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru OTC Pet Medication Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia OTC Pet Medication Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel OTC Pet Medication Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE OTC Pet Medication Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey OTC Pet Medication Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran OTC Pet Medication Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt OTC Pet Medication Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt OTC Pet Medication Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt OTC Pet Medication Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck Inc.
  2. 8.1.1 Merck Inc. Company Information
  3. 8.1.2 Merck Inc. Business Overview
  4. 8.1.3 Merck Inc. OTC Pet Medication Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Inc. OTC Pet Medication Product Portfolio
  6. 8.1.5 Merck Inc. Recent Developments
  7. 8.2 Zymox
  8. 8.2.1 Zymox Company Information
  9. 8.2.2 Zymox Business Overview
  10. 8.2.3 Zymox OTC Pet Medication Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zymox OTC Pet Medication Product Portfolio
  12. 8.2.5 Zymox Recent Developments
  13. 8.3 Zoetis Inc.
  14. 8.3.1 Zoetis Inc. Company Information
  15. 8.3.2 Zoetis Inc. Business Overview
  16. 8.3.3 Zoetis Inc. OTC Pet Medication Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zoetis Inc. OTC Pet Medication Product Portfolio
  18. 8.3.5 Zoetis Inc. Recent Developments
  19. 8.4 Virbac SA
  20. 8.4.1 Virbac SA Company Information
  21. 8.4.2 Virbac SA Business Overview
  22. 8.4.3 Virbac SA OTC Pet Medication Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Virbac SA OTC Pet Medication Product Portfolio
  24. 8.4.5 Virbac SA Recent Developments
  25. 8.5 Vetoquinol SA
  26. 8.5.1 Vetoquinol SA Company Information
  27. 8.5.2 Vetoquinol SA Business Overview
  28. 8.5.3 Vetoquinol SA OTC Pet Medication Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vetoquinol SA OTC Pet Medication Product Portfolio
  30. 8.5.5 Vetoquinol SA Recent Developments
  31. 8.6 Sulfox
  32. 8.6.1 Sulfox Company Information
  33. 8.6.2 Sulfox Business Overview
  34. 8.6.3 Sulfox OTC Pet Medication Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sulfox OTC Pet Medication Product Portfolio
  36. 8.6.5 Sulfox Recent Developments
  37. 8.7 Nutramax Laboratories, Inc.
  38. 8.7.1 Nutramax Laboratories, Inc. Company Information
  39. 8.7.2 Nutramax Laboratories, Inc. Business Overview
  40. 8.7.3 Nutramax Laboratories, Inc. OTC Pet Medication Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nutramax Laboratories, Inc. OTC Pet Medication Product Portfolio
  42. 8.7.5 Nutramax Laboratories, Inc. Recent Developments
  43. 8.8 Frontline
  44. 8.8.1 Frontline Company Information
  45. 8.8.2 Frontline Business Overview
  46. 8.8.3 Frontline OTC Pet Medication Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Frontline OTC Pet Medication Product Portfolio
  48. 8.8.5 Frontline Recent Developments
  49. 8.9 Elanco
  50. 8.9.1 Elanco Company Information
  51. 8.9.2 Elanco Business Overview
  52. 8.9.3 Elanco OTC Pet Medication Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Elanco OTC Pet Medication Product Portfolio
  54. 8.9.5 Elanco Recent Developments
  55. 8.10 Dechra Pharmaceuticals PLC
  56. 8.10.1 Dechra Pharmaceuticals PLC Company Information
  57. 8.10.2 Dechra Pharmaceuticals PLC Business Overview
  58. 8.10.3 Dechra Pharmaceuticals PLC OTC Pet Medication Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Dechra Pharmaceuticals PLC OTC Pet Medication Product Portfolio
  60. 8.10.5 Dechra Pharmaceuticals PLC Recent Developments
  61. 8.11 ChloraSeb
  62. 8.11.1 ChloraSeb Company Information
  63. 8.11.2 ChloraSeb Business Overview
  64. 8.11.3 ChloraSeb OTC Pet Medication Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ChloraSeb OTC Pet Medication Product Portfolio
  66. 8.11.5 ChloraSeb Recent Developments
  67. 8.12 Ceva Sante Animale
  68. 8.12.1 Ceva Sante Animale Company Information
  69. 8.12.2 Ceva Sante Animale Business Overview
  70. 8.12.3 Ceva Sante Animale OTC Pet Medication Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ceva Sante Animale OTC Pet Medication Product Portfolio
  72. 8.12.5 Ceva Sante Animale Recent Developments
  73. 8.13 Boehringer Ingelheim Animal Health
  74. 8.13.1 Boehringer Ingelheim Animal Health Company Information
  75. 8.13.2 Boehringer Ingelheim Animal Health Business Overview
  76. 8.13.3 Boehringer Ingelheim Animal Health OTC Pet Medication Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Boehringer Ingelheim Animal Health OTC Pet Medication Product Portfolio
  78. 8.13.5 Boehringer Ingelheim Animal Health Recent Developments
  79. 8.14 Bayer Companion Animal
  80. 8.14.1 Bayer Companion Animal Company Information
  81. 8.14.2 Bayer Companion Animal Business Overview
  82. 8.14.3 Bayer Companion Animal OTC Pet Medication Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bayer Companion Animal OTC Pet Medication Product Portfolio
  84. 8.14.5 Bayer Companion Animal Recent Developments
  85. 8.15 Adequan
  86. 8.15.1 Adequan Company Information
  87. 8.15.2 Adequan Business Overview
  88. 8.15.3 Adequan OTC Pet Medication Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Adequan OTC Pet Medication Product Portfolio
  90. 8.15.5 Adequan Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst